Medicenna Therapeutics to Present at Upcoming September Investor Conferences
TORONTO and HOUSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced that Dr. Fahar Merchant, President, CEO and Chairman of the Board of Medicenna, will be presenting at the following virtual investor conferences to take place in September, 2021.
Details are as follows:
H.C. Wainwright 23rd Annual Global Investment Conference
Format: Panel Discussion - Engineered Cytokines: The Next Big Wave in Immuno-oncology
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Cantor Virtual Global Healthcare Conference
Webcast and replay information for these events, as applicable, will be available on the Investor Relations section of Medicenna's website at https://ir.medicenna.com/.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Except as required by law, we do not intend and do not assume any obligation to update or revise publicly any of the included forward-looking statements.
Further Information For further information about the Company please contact: Elizabeth Williams, Chief Financial Officer, 416-648-5555, firstname.lastname@example.org Investor Contact For more investor information, please contact: Dan Ferry, Managing Director, LifeSci Advisors, 617-430-7576, email@example.com
Getting to the Relevant (meta) Data
Keynote Presentation - Open to all Badge Holders